Park Medi World Ltd (PARKHOSPS) — share price & stock analysis
Profits have nearly doubled in two years.
Park Medi World Ltd (PARKHOSPS) trades at ₹295 as of 1 July 2026. The machine reads this as steady growth: profits have nearly doubled in two years. the price is in Stage 2 — advancing, 22 weeks in; the business cycle reads DEEP CYCLICAL / EXPANSION. Fundamentals-momentum score: 90/100 (all improving).
Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.
- Market cap
- ₹12,757 Cr
- P/E
- 49.4×
- ROE
- 16.7%
- Book value / share
- ₹46.8
- Revenue (FY26)
- ₹1,679 Cr
- Profit after tax (FY26)
- ₹274 Cr
- Weinstein stage
- Stage 2 (22 weeks)
- Data as of
- 1 July 2026
Profits swing violently in this business — margins swinging 15 points peak to trough. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.net_profit
Where the clock stands now: earnings sit at 100% of their historical range, margins are near the bottom of their band, and valuation history is thin. That reads as EXPANSION — the middle of the cycle with margins still near their own lows — if margins mean-revert upward there is fuel left; if they don’t, growth has to do all the work.net_profit
One tension to hold: profits are compounding while margins sit near the bottom of their own historical band. That cuts both ways — there is recovery left to collect if margins climb back, but it also means today’s growth is being earned on thin economics.
5 of the 5 things we track are currently moving the right way — nearly everything is pulling in the same direction.
Where the levels actually stand: ROCE 19% — decent; effectively no debt; margins near the bottom of their band. Momentum says which way things are moving; these say where they are.
Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double, and a quarter of the score comes from our earnings-recovery lens (is the profit cycle turning up off its trough?).
The price is in a confirmed uptrend — 22 weeks and counting
STAGE 2 · ADVANCING · 22 WEEKSStock prices move through four repeating stages: basing (1), advancing (2), topping (3) and declining (4). This one is in Stage 2: advancing, 22 weeks in, confirmed.stage
The price sits above its rising 200-day average (₹205 today) — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200
What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200
Data: Weekly price, moving averages and stage
| Period | Price (₹) | 200-DMA (₹) | 50-DMA (₹) | Stage |
|---|---|---|---|---|
| Dec 25 | 155 | 148 | 149 | 4 |
| Dec 25 | 146 | 148 | 148 | 4 |
| Jan 26 | 150 | 148 | 148 | 4 |
| Jan 26 | 149 | 148 | 148 | 4 |
| Jan 26 | 151 | 148 | 149 | 1 |
| Jan 26 | 156 | 149 | 150 | 1 |
| Feb 26 | 151 | 149 | 150 | 1 |
| Feb 26 | 153 | 149 | 151 | 1 |
| Feb 26 | 176 | 150 | 154 | 1 |
| Feb 26 | 184 | 151 | 159 | 2 |
| Feb 26 | 193 | 153 | 165 | 2 |
| Mar 26 | 203 | 155 | 169 | 2 |
| Mar 26 | 193 | 157 | 175 | 2 |
| Mar 26 | 199 | 159 | 178 | 2 |
| Mar 26 | 200 | 161 | 181 | 2 |
| Apr 26 | 197 | 162 | 183 | 2 |
| Apr 26 | 210 | 164 | 187 | 2 |
| Apr 26 | 217 | 165 | 190 | 2 |
| Apr 26 | 233 | 168 | 197 | 2 |
| Apr 26 | 231 | 171 | 202 | 2 |
| May 26 | 250 | 175 | 210 | 2 |
| May 26 | 245 | 178 | 217 | 2 |
| May 26 | 259 | 182 | 224 | 2 |
| May 26 | 289 | 186 | 233 | 2 |
| Jun 26 | 286 | 190 | 240 | 2 |
| Jun 26 | 282 | 191 | 242 | 2 |
| Jun 26 | 293 | 193 | 245 | 2 |
| Jun 26 | 280 | 193 | 247 | 2 |
| Jun 26 | 275 | 195 | 249 | 2 |
| Jun 26 | 254 | 197 | 251 | 2 |
| Jun 26 | 278 | 198 | 252 | 2 |
| Jun 26 | 288 | 201 | 256 | 2 |
| Jun 26 | 286 | 202 | 257 | 2 |
| Jul 26 | 295 | 205 | 261 | 2 |
Profits have grown in 4 of the last 5 years — compounding so far, on a short record
Over 5 years, sales went from ₹766 Cr to ₹1,679 Cr (about 17% a year), and profit from ₹187 Cr to ₹274 Cr.revenuenet_profit
Margins gave up 13.9 points along the way — growth bought at a price.operating_profit
Data: Revenue by year
| Period | Revenue (₹ Cr) |
|---|---|
| FY21 | 766 |
| FY22 | 1,084 |
| FY23 | 1,255 |
| FY24 | 1,231 |
| FY25 | 1,394 |
| FY26 | 1,679 |
Data: Profit by year
| Period | Profit after tax (₹ Cr) |
|---|---|
| FY21 | 187 |
| FY22 | 199 |
| FY23 | 228 |
| FY24 | 152 |
| FY25 | 213 |
| FY26 | 274 |
Data: OPM % by year
| Period | OPM % (%) |
|---|---|
| FY21 | 40.3 |
| FY22 | 31.8 |
| FY23 | 31.2 |
| FY24 | 25.3 |
| FY25 | 26.9 |
| FY26 | 26.4 |
Sales jumped 30% last quarter
Mar 26 sales were ₹460 Cr, up 30% on the same quarter last year.revenue
Data: Quarterly sales
| Period | Revenue (₹ Cr) | YoY growth (%) |
|---|---|---|
| Dec 24 | 348 | – |
| Mar 25 | 354 | – |
| Sep 25 | 410 | – |
| Dec 25 | 410 | 17.8 |
| Mar 26 | 460 | 29.9 |
Margins are widening — 25% → 28% in a year
Of every ₹100 of sales, the company keeps ₹27.7 as operating profit (a year ago it kept ₹25.0).opm_pct
The gross margin barely moved (82% → 83%), so the change came from running costs — the business is getting more efficient as it scales.gpm_pctopm_pct
Data: Three margins, quarterly
| Period | Gross (%) | Operating (%) | Net (%) |
|---|---|---|---|
| Sep 24 | 78.5 | 27.4 | 16.3 |
| Dec 24 | 79.2 | 23.8 | 13.1 |
| Mar 25 | 82.3 | 25.0 | 14.8 |
| Sep 25 | 82.8 | 27.5 | 19.1 |
| Dec 25 | 81.6 | 24.3 | 12.9 |
| Mar 26 | 82.7 | 27.7 | 16.7 |
Profit exploded 48% — mostly from selling more
Mar 26 profit after tax was ₹77.0 Cr, up 48% year on year.net_profit
Data: Quarterly profit after tax
| Period | PAT (₹ Cr) | YoY growth (%) |
|---|---|---|
| Dec 24 | 46.0 | – |
| Mar 25 | 52.0 | – |
| Sep 25 | 79.0 | – |
| Dec 25 | 53.0 | 15.2 |
| Mar 26 | 77.0 | 48.1 |
The single biggest driver was selling more.
Data: Where the profit change came from (Mar 25 → Mar 26)
| Component | Effect (₹ Cr) |
|---|---|
| PAT Mar 25 | 52 |
| More sales | +26 |
| Fatter margins | +13 |
| Other income | −1 |
| Depreciation | −2 |
| Interest | +2 |
| Tax | −12 |
| Everything else | −1 |
| PAT Mar 26 | 77 |
The profits are real — they turn into cash
Over the last 5 profitable years, the business reported ₹1,066 Cr of profit and collected ₹1,235 Cr of operating cash — about 116% conversion.operating_cash_flownet_profit
When cash tracks profit this closely, the earnings need no asterisk.
Data: Cash collected vs profit reported (annual)
| Period | Operating cash flow (₹ Cr) | Profit after tax (₹ Cr) |
|---|---|---|
| FY21 | 223 | 187 |
| FY22 | 155 | 199 |
| FY23 | 199 | 228 |
| FY24 | 361 | 152 |
| FY25 | 191 | 213 |
| FY26 | 329 | 274 |
The cash cycle is tightening — money comes home faster
One rupee now takes about -2 days to go out the door as materials and come back as collected cash — down from 161 days the year before.cash_conversion_cycle
The biggest mover: customers paying faster (161 → 129 days).debtor_days
Data: Days of cash locked up (annual)
| Period | Customers owe (debtor days) (days) | Stock on shelf (inventory days) (days) | We owe suppliers (payable days) (days) |
|---|---|---|---|
| FY21 | 151 | 47.0 | 121 |
| FY22 | 151 | 14.0 | 101 |
| FY23 | 168 | 3.0 | 110 |
| FY24 | 151 | – | – |
| FY25 | 161 | – | – |
| FY26 | 129 | 4.0 | 134 |
The asset base keeps compounding — this company builds
The productive asset base has gone from ₹365 Cr (FY21) to ₹1,309 Cr, with another ₹123 Cr of capacity under construction right now.fixed_assetscwip
The build is self-funded: the last 3 years' investing outflow (₹679 Cr) fits inside the operating cash the business generated (₹881 Cr).investing_cash_flowoperating_cash_flow
Data: Assets in place vs under construction (annual)
| Period | Fixed assets (₹ Cr) | Under construction (CWIP) (₹ Cr) |
|---|---|---|
| FY21 | 365 | 7.0 |
| FY22 | 458 | 29.0 |
| FY23 | 536 | 5.0 |
| FY24 | 837 | 32.0 |
| FY25 | 898 | 37.0 |
| FY26 | 1,309 | 123 |
Almost no debt — this company cannot be killed by a bad year
For every ₹100 shareholders have put in (and left in), the company has borrowed ₹18.borrowings
Data: Total borrowings (annual)
| Period | Borrowings (₹ Cr) |
|---|---|
| FY21 | 292 |
| FY22 | 517 |
| FY23 | 576 |
| FY24 | 687 |
| FY25 | 682 |
| FY26 | 364 |
Data: Debt vs shareholders’ money (annual)
| Period | Debt ÷ equity (x) |
|---|---|
| FY21 | 1.1 |
| FY22 | 1.1 |
| FY23 | 0.8 |
| FY24 | 0.8 |
| FY25 | 0.6 |
| FY26 | 0.2 |
Every ₹100 kept in the business earns ₹19 — decent, not special
Return on capital employed is 19.0% (a year ago: 20.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct
Data: Returns on capital (annual)
| Period | ROCE (%) |
|---|---|
| FY22 | 38.0 |
| FY23 | 31.0 |
| FY24 | 20.0 |
| FY25 | 20.0 |
| FY26 | 19.0 |
Worth studying deeper — with eyes open
The numbers lean positive, and the price is roughly fair to the delivery so far.
Best thing in the data: cash generation rising (₹191 Cr → ₹329 Cr).operating_cash_flow
Biggest worry: free cash flow falling (₹100 Cr → ₹−4.0 Cr).operating_cash_flow
One dissent worth hearing: our valuation lens reads negative — “its fair-value math says the price sits about 30% above what the numbers justify”. When a lens disagrees with the committee, it is usually pointing at the thing that breaks first.
Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.
Straight answers from the data
What does Park Medi World Ltd do?
Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.(Source : 202503 Annual Report Page No:320). It is listed in the Hospitals/Medical Services sector with a market capitalisation of ₹12,757 Cr.
What is Park Medi World Ltd's share price?
As of 1 July 2026, Park Medi World Ltd trades at ₹295, with a market capitalisation of ₹12,757 Cr. Prices are weekly closes from Screener data; this page refreshes with each weekly update.
What is Park Medi World Ltd's share price target?
Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates Park Medi World Ltd's intrinsic value at ₹246 per share under base assumptions (bear ₹105, bull ₹337), against the current price of ₹295 — a 14% premium to model value. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.
What did Park Medi World Ltd report in its latest quarterly results?
In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹460 Cr, up 30% on the same quarter last year. Mar 26 profit after tax was ₹77.0 Cr, up 48% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.
Is Park Medi World Ltd growing?
Sales jumped 30% last quarter. Mar 26 sales were ₹460 Cr, up 30% on the same quarter last year.
Are Park Medi World Ltd's profits growing?
Profit exploded 48% — mostly from selling more. Mar 26 profit after tax was ₹77.0 Cr, up 48% year on year.
What are Park Medi World Ltd's operating margins?
Margins are widening — 25% → 28% in a year. In the most recent quarter, of every ₹100 of sales, the company keeps ₹27.7 as operating profit (a year ago it kept ₹25.0).
What is Park Medi World Ltd's long-term growth record?
Revenue grew from ₹766 Cr in FY21 to ₹1,679 Cr in FY26 — a 17.0% compound annual growth rate over 5 years. Profit after tax compounded at 7.9% over the same period (₹187 Cr → ₹274 Cr).
Is Park Medi World Ltd stock in an uptrend?
The price is in a confirmed uptrend — 22 weeks and counting. Park Medi World Ltd is in Stage 2 — advancing, 22 weeks in (confirmed). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).
Where is Park Medi World Ltd in its business cycle?
The data reads Park Medi World Ltd as a deep cyclical business currently in its expansion phase — earnings at an all-time high for this company. Profits swing violently in this business — margins swinging 15 points peak to trough. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.
Does Park Medi World Ltd have too much debt?
Almost no debt — this company cannot be killed by a bad year. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹18.
What is the bull case for Park Medi World Ltd?
Profits have nearly doubled in two years. Best thing in the data: cash generation rising (₹191 Cr → ₹329 Cr). Sales jumped 30% last quarter.
What is the bear case for Park Medi World Ltd — what could break the story?
Biggest worry: free cash flow falling (₹100 Cr → ₹−4.0 Cr). Two quarters of margins reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 15%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.
Is Park Medi World Ltd a stock worth studying right now?
Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: worth studying deeper — with eyes open. The numbers lean positive, and the price is roughly fair to the delivery so far. Across the 7-model scorecard the composite research signal is study deeper at 78% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.